If my LDL-C is “normal,” am I safe?

Not always. LDL-C measures the weight of cholesterol, not how many particles are carrying it. If your triglycerides are high and your HDL is low (a Trig/HDL ratio above 1.5), you likely have phenotype B (many small, dense LDL particles) and high ApoB – meaning higher risk even with “normal” LDL. Ask your doctor for an ApoB test.

Is a statin the only answer?

Statins (cholesterol-lowering drugs) work well and are the right choice in some cases – that is a decision for you and your doctor. But lifestyle changes (diet, movement, sleep, insulin sensitivity – how well your cells respond to insulin) can improve particle number, particle size, and inflammation as much as a drug alone, and they work well together with statins.

Can Lp(a) be treated?

Lifestyle changes barely affect Lp(a) (a genetic, LDL-like particle linked to heart risk). If your Lp(a) is high, the focus shifts to controlling everything else more strictly: LDL/ApoB, hs-CRP, blood pressure, and smoking. New RNA-based drugs are being tested in clinical trials.

Why do homocysteine and fibrinogen matter?

Homocysteine (an amino acid that can damage blood vessels) harms the artery lining directly. High levels speed up atherosclerosis (plaque buildup in the arteries) even when LDL is low. Fibrinogen (a blood-clotting protein) raises the risk of clots. Both can be improved with B vitamins, lifestyle changes, and stress management, and both belong on a thorough lipid panel.

Should I get a coronary artery calcium (CAC) scan?

After age 40, especially with family risk or uncertainty, a CAC scan (a scan that measures calcium buildup in the heart’s arteries) is one of the most useful single tests. It shows whether plaque has already started to build up. A score of 0 means very low risk over the next 10 years. A score above 100 means doctors usually recommend stronger prevention steps.

Miks LDL üksi ei ole piisav marker?

LDL mõõdab kolesterooli hulka, aga mitte osakeste arvu ega tihedust. Kahel inimesel sama LDL-iga võib olla kardiovaskulaarrisk 3× erinev, kui ühel on väikesed tihedad LDL-osakesed (B-fenotüüp) ja teisel suured kohevad (A-fenotüüp). ApoB mõõdab osakeste arvu – see on täpsem.

Mis on ApoB ja miks see loeb?

ApoB (apolipoproteiin B) on valk igal aterogeensel osakesel (LDL, VLDL, IDL, Lp(a)). Üks osake = üks ApoB. ApoB > 90 mg/dl on kõrge risk sõltumata LDL-ist. ESC/EAS 2019. aasta juhendid soovitavad ApoB-d kasutada riskihinnangu täiendava näitajana.

Millal peaks laske mõõta Lp(a)?

Vähemalt ÜKS kord elu jooksul igal täiskasvanul (ESC 2019, EAS 2022). Lp(a) on geneetiline – kui isal või emal oli varajane infarkt ( 50 mg/dl) tõstab südameinfarkti riski 2–3×.

Kas madal-süsivesikuline dieet tõstab LDL-i ja kas see on ohtlik?

Ligikaudu 30%-l inimestest tõuseb LDL keto/low-carbil („hyper-responder“ fenotüüp). Aga sageli tõuseb SUURTE osakeste LDL-A, mitte väikeste tihedatega LDL-B – riskiprofiil võib paraneda (kõrgem HDL, madalam trig). Vaja on ApoB ja tervikpilti, mitte üksnes LDL-i.

Kas statin on ainuke lahendus kõrge kolesterooli puhul?

Ei – aga see on üks tõenduspõhiseimaid ravimeid. Alternatiivid ja täiendused: bergamott, punase riisi pärm (naturaalne statin), niatsiin, oomega-3, kiudained, taimestanoolid. Ravim valik sõltub baasjoonest, riskist, taluvusest. Elustiil on alati alus.

Millised toidud alandavad LDL-i tõenduspõhiselt?

Lahustuvad kiudained (kaerakleepud, chia, oad), kreeka pähklid ja mandlid, oliiviõli ja avokaado, taimestanoolid (2 g/päevas → 10% LDL langus), rasvane kala (oomega-3), rohelised köögiviljad. Portfoolio-dieet vähendab LDL-i keskmiselt 30%.

Kas munad tõstavad kolesterooli?

Enamikul inimestest – ei. Toidukolesterool on ~15% vere kolesteroolist; keha reguleerib maksast sünteesi. 1–3 muna päevas on suurel enamusel ohutu. Erand: „hyper-responder“ fenotüüp (25% inimestest) – kontrolli labor 6 nädala pärast.

Mis on „aterogeenne diabeetiline düslipideemia“?

Insuliiniresistentsuse tüüpiline pilt: kõrged triglütseriidid, madal HDL, väikesed tihedad LDL-osakesed (B-fenotüüp), tõusnud ApoB. LDL üksi võib olla „normis“, aga risk on kõrge. See on peamine põhjus miks IR-i lehe ja Kolesterooli lehe teemad on seotud.

Kas oomega-3 lisandid vähendavad kardiovaskulaarriski?

EPA-le keskendunud preparaadid (nt icosapent) näitasid tugevat efekti (REDUCE-IT uuring, 25% MACE vähenemine). Segastest EPA+DHA preparaatidest on tõendus segasem. Suurte annuste (2–4 g/päev) puhul alati arstiga.

Millal peaks laske mõõta homotsüsteiini?

Kui perekonnas on varajane ateroskleroos, tromboosid, aju-insult; kui on B12/folaadi puudus, hüpotüreoos, teatavaid geneetilisi variantide (MTHFR) kahtlus. Homotsüsteiin > 10 µmol/l on kardiovaskulaarne riskitegur; > 15 µmol/l – selge patoloogia.

Health monitoring

Heart & vascular health

Cholesterol, ApoB and the lipoprotein profile

“High cholesterol” is one of the most misunderstood results in modern medicine – sometimes overblown, sometimes overlooked. What matters most for your health isn’t total cholesterol or even LDL-C alone. It’s the number of cholesterol-carrying particles in your blood (measured as ApoB), how big those particles are (called phenotype A or B), Lp(a) (a genetic risk particle), and inflammation markers like hs-CRP, homocysteine, and fibrinogen.

ApoB (a marker of particle count) matters more than LDL-C alone
Small, dense LDL particles (phenotype B) are much more dangerous
Lp(a), hs-CRP, homocysteine, and fibrinogen are often skipped but clinically important

Book a consultation 5 tests for metabolic health

Arst vaatab laiendatud lipiidipaneeli tulemusi

What cholesterol is – and why the standard test misses half the picture

Cholesterol is not a “bad substance.” It’s the raw material for every cell membrane, for hormones like testosterone, estrogen, and cortisol, and for vitamin D. Your liver makes about 80% of the cholesterol in your blood; only about 20% comes from food.

Cholesterol doesn’t dissolve in water, so it travels through the blood inside carrier particles called lipoproteins – LDL, VLDL, IDL, HDL, and Lp(a). Every one of these particles carries a protein called apolipoprotein B (ApoB) on its surface, except HDL, which carries ApoA instead. Measuring ApoB tells you exactly how many artery-clogging particles you have – something the standard “LDL cholesterol” number (measured in weight) cannot show.

Two people can have the same LDL-C (say 3.5 mmol/L) but very different risk. One may have large, fluffy LDL particles in small numbers (phenotype A – lower risk). The other may have many small, dense LDL particles (phenotype B – higher risk). Same amount of cholesterol, very different risk.

Warning signs and a higher-risk profile

Trig/HDL ratio above 1.5 – an indirect sign of phenotype B (small, dense LDL) and insulin resistance
Family history of an early heart attack (before 55 in men, before 65 in women)
Diagnosed familial hypercholesterolemia (FH – an inherited condition that causes very high cholesterol)
Xanthelasma (yellow patches on the eyelids) or a gray ring around the cornea before age 50
Thickening of the arteries seen on a carotid or abdominal ultrasound
Metabolic syndrome: extra belly fat, high blood pressure, and insulin resistance together
An ongoing inflammatory condition (autoimmune disease, gum disease, inflammatory bowel disease)
Smoking and chronic stress – both speed up atherosclerosis (plaque buildup) even with “normal” LDL

Why ApoB matters more than LDL-C

A plaque starts to form when a particle carrying ApoB (a protein tag on artery-clogging particles) gets stuck in the artery wall. What matters is how many particles are knocking at the door – not how many grams of cholesterol they carry. Every LDL, VLDL, IDL, and Lp(a) particle carries exactly one ApoB molecule, so counting ApoB gives you a direct particle count.

Large studies (Sniderman, Circulation 2019; INTERHEART) show that ApoB predicts heart attacks and strokes more accurately than LDL-C. This matters most when the two disagree: someone with “normal” LDL-C but high ApoB is still at high risk.

Particle size: phenotype A vs. phenotype B

Phenotype A – larger, fluffier LDL particles, fewer of them, lower risk
Phenotype B – small, dense LDL particles (sdLDL), more of them, higher risk
Phenotype B tends to appear with insulin resistance, high triglycerides, and low HDL
A Trig/HDL ratio above 1.5 (mmol/L) or 3.5 (mg/dL) is a strong sign of phenotype B
Small, dense LDL particles slip into the artery wall more easily and oxidize (break down chemically) more easily too – both make them more dangerous

Four pillars for a healthier lipid profile

A statin (cholesterol-lowering drug) is just one tool. Lifestyle works alongside it and directly changes particle number, particle size, and inflammation.

Nutrition

Cut back on refined carbs and sugary drinks – the biggest drivers of high triglycerides and phenotype B (small, dense LDL particles). Eat more fiber (30+ g a day), omega-3 fats, and monounsaturated fats (olive oil, avocado, nuts). Losing 5–10% of your body weight often lowers ApoB (particle count) by 15–25%.

Insulin sensitivity

Phenotype B and high triglycerides are usually caused by insulin resistance (when cells respond poorly to insulin). Lowering insulin levels – through an 8–10 hour eating window, strength training, and good sleep – can improve your lipid profile more than medication alone.

Supplements that can support your lipids and blood vessels

Supplements don’t replace statins (cholesterol-lowering drugs) when your doctor says you need one. But several can support healthy lifestyle changes and improve markers that statins don’t touch.

Omega-3 (EPA/DHA fatty acids, 2–4 g/day) – lowers triglycerides by 20–30% and reduces inflammation
Berberine – lowers LDL-C and ApoB (particle count) by about 15% and improves insulin sensitivity; check for drug interactions first
Red yeast rice (contains monacolin K) – works like a statin; don’t combine it with an actual statin
B12, folate (in methyl form), B6, and betaine (TMG) – lower homocysteine (an amino acid that can damage blood vessels)
Vitamin K2 (MK-7) – helps direct calcium into bones instead of arteries (best paired with vitamin D)
CoQ10 (ubiquinol) – supports cell energy production, especially if you take a statin
Nattokinase – may lower fibrinogen (a blood-clotting protein) and help break down clots (research is still ongoing)
Plant sterols and fiber (such as psyllium) – reduce how much cholesterol your gut absorbs

Fasting and your lipid profile

Time-restricted eating (eating only within a set window each day) and periodic fasting can lower triglycerides, shift LDL toward the safer phenotype A, and lower ApoB. This likely happens because fasting improves insulin sensitivity (how well your cells respond to insulin).

In a 2019 study (Tinsley et al., Am J Clin Nutr), an 8-hour eating window combined with strength training improved the lipid profile and body composition in adults with excess weight, including triglycerides and fat mass.

Fasting is not right for everyone. Avoid it during pregnancy or breastfeeding, if you have a history of an eating disorder, or if you take certain medicines (like insulin or sulfonylureas) without medical supervision.

See the study (Am J Clin Nutr)

Expanded lipid panel – what to ask for

ApoB (a protein that marks each artery-clogging particle) – a direct particle count (target under 0.9 g/L; under 0.65 if you’re high risk)
Lp(a) (a genetic, LDL-like particle) – test at least once in your life (target under 30 mg/dL / 75 nmol/L)
LDL-C, HDL-C, triglycerides, total cholesterol (the standard panel)
Trig/HDL ratio – an indirect sign of phenotype B (small, dense LDL) and insulin resistance
Non-HDL cholesterol – all artery-clogging particles combined
hs-CRP (a sensitive marker of inflammation) – vascular inflammation (target under 1 mg/L)
Homocysteine (an amino acid that can damage blood vessels; target under 8 μmol/L)
Fibrinogen (a blood-clotting protein; target under 3.5 g/L)
Fasting insulin and HOMA-IR (a score that estimates insulin resistance) – the root cause of phenotype B
Thyroid tests (TSH, free T3) – an underactive thyroid raises LDL
Vitamin D and ferritin (a marker of iron stores) – for overall context
Coronary artery calcium score (CAC – a scan that measures calcium buildup in heart arteries) from age 40 – shows plaque directly

Want to know your real cardiac risk?

In the consultation we review your expanded lipid panel (ApoB, Lp(a), hs-CRP, homocysteine, fibrinogen), the CAC score and build an individual plan you can discuss with your GP and/or cardiologist.

Book a consultation Pay later or in installments – via Montonio at checkout

Dr Sergey Saadi – preventive medicine physician

Address root causes – three steps with Dr Saadi

Dr Sergey Saadi is a preventive medicine physician with 15+ years of practice, specializing in metabolic health, weight management and the root causes of chronic metabolic dysfunction. Pick the step that matches your current question.

Step 1
Start here€490
Individual consultation (45 min)
We review your labs, symptoms and history. You leave with a clear picture of what’s happening in your body and which next steps fit you – with reasoning, not generic advice.
Book a consultation
Step 2
Structured supportfrom €1900
Guided monitoring (30, 60 or 90 days)
Three to four consultations + concierge support on Telegram (Mon–Fri). A systemic plan for nutrition, sleep, training load and, where needed, medications and supplements – a longer-term format for managing metabolic health with a physician.
See monitoring packages
Step 3
Deep dive€490
TellmeGen Advanced genetic test
400+ health markers and 700,000+ SNPs. Lifetime access to your report (updates as science advances). Includes a 45-minute physician interpretation.
Explore the test

Lipiidiprofiili sihttasemed

Sihtväärtused sõltuvad kardiovaskulaarsest riskist (ESC 2019, EAS 2022)

Marker	Madal risk	Mõõdukas / kõrge risk	Väga kõrge risk
LDL-kolesterool	< 3,0 mmol/l	< 2,6 mmol/l	< 1,4 mmol/l
ApoB	< 100 mg/dl	< 80 mg/dl	< 65 mg/dl
Triglütseriidid	< 1,7 mmol/l	< 1,5 mmol/l	< 1,5 mmol/l
HDL-kolesterool (M / N)	> 1,0 / > 1,2 mmol/l	sama	sama
Lp(a)	< 30 mg/dl (< 75 nmol/l)	sama	sama
Non-HDL kolesterool	< 3,8 mmol/l	< 3,4 mmol/l	< 2,2 mmol/l
Homotsüsteiin	< 10 µmol/l	< 10 µmol/l	< 10 µmol/l

LDL-kolesterool

Madal risk: < 3,0 mmol/l
Mõõdukas / kõrge risk: < 2,6 mmol/l
Väga kõrge risk: < 1,4 mmol/l

ApoB

Madal risk: < 100 mg/dl
Mõõdukas / kõrge risk: < 80 mg/dl
Väga kõrge risk: < 65 mg/dl

Triglütseriidid

Madal risk: < 1,7 mmol/l
Mõõdukas / kõrge risk: < 1,5 mmol/l
Väga kõrge risk: < 1,5 mmol/l

HDL-kolesterool (M / N)

Madal risk: > 1,0 / > 1,2 mmol/l
Mõõdukas / kõrge risk: sama
Väga kõrge risk: sama

Lp(a)

Madal risk: < 30 mg/dl (< 75 nmol/l)
Mõõdukas / kõrge risk: sama
Väga kõrge risk: sama

Non-HDL kolesterool

Madal risk: < 3,8 mmol/l
Mõõdukas / kõrge risk: < 3,4 mmol/l
Väga kõrge risk: < 2,2 mmol/l

Homotsüsteiin

Madal risk: < 10 µmol/l
Mõõdukas / kõrge risk: < 10 µmol/l
Väga kõrge risk: < 10 µmol/l

Väga kõrge risk = varasem infarkt/insult, diabeet + kahjustus, krooniline neerukahjustus, familiaalne hüperkolesteroleemia. ApoB on täpsem kui LDL üksi.

Frequently asked questions

Go deeper: related materials

Articles

Guides

Webinars

All webinars

Courses

All courses

Dr Sergey Saadi – expert in advanced lipidology and metabolic health

Dr Sergey Saadi is a physician with over 15 years of clinical practice.

Clinical approach: ApoB + Lp(a) + hs-CRP + homocysteine + fibrinogen – not just LDL-C
Regular speaker in media and in clinician training
Author of “Dangerous secrets of blood sugar” (Varrak)

Alternative path

Go deeper: lipidology and cardiovascular webinars

Recorded webinars on ApoB, lipoproteins and cardiovascular risk assessment – with Dr Saadi.

See webinars

This page is educational and general. It is not personal medical advice, a diagnosis or a treatment plan. Discuss changes with your doctor.